Partner with us

We tailor our technology to your needs

Every drug deserves the best chance to make a real difference. That’s why we’ve built our patented lipid nanoemulsions to be adaptable, scalable, and above all, safe.our cutting-edge delivery technology that increases the potential for translating your molecule to the clinic. Our promise? Developing testable prototypes within just 8 weeks.

Versatility and scalability

Ready for industrial and regulatory scaling

Our patented lipid nanoemulsions are safe-by-design. All our excipients are part of the pharmacopoeia. Our technology is scalable and replicable, increasing the potential for translating your product to the clinic. Fast exploratory formulation turnaround time: testable prototypes within 8 weeks. We want to help you with your project.

Our technology can also be adapted to many other applications beyond therapeutics, in fields such as nutraceuticals and cosmetics.

Adapting to industrial modelseady for industrial and regulatory scaling

We are collaborating with CDMOs that can manufacture the formulations under GMP regulations. Adaptation of the manufacturing process to industrial requirements has been possible thanks to the simplicity of our approach.

Regulatory assessment

Safe-by-design nanosystems

The main components of our lipid nanoemulsions are not new to the pharmaceutical world, they are already excipients in pharmaceutical or cosmetic products that are administered by the oral, topical, and intravenous routes.

logos partners and customers
logos partners and customers
logos partners and customers

Partners and Customers

Meet the companies, associations and institutions relying on us

Flexible Collaboration Schemes to fit your stage of research

Adaptable to different research stages

Perfect for in vitro and in vivo validation. We will develop characterized formulation prototypes associating your active drug of interest and deliver a detailed report outlining the properties of the selected formulations.

We will also provide advice on the experimental protocol design for validation.

Material transfer from customer
Free product study & conceptualization
DIVERSA formulation development
Product development
Service agreement
Technical documents
Testable prototypes
1st production included (batch)
License agreement
Option to a sublicence agreementicense agreement

Free product study & conceptualization

Consisting on the preliminary assessment that is conducted to determine the practicality and viability of using our technology to associate your drug/biomolecule and solve the problems that might be limiting its translation to the clinic.  Our expert team conducts an in-depth theoretical analysis to assess how your molecule would interact with our patented drug delivery solution, at absolutely no cost to you.

Product Development (8-12 weeks)

Consists of optimizing the formulation for the indication of interest, for in vitro and/or in vivo assessment and validation, considering factors like identified biopharmaceutical problems, target dosage and route of administration.

  • Feasibility evaluation: Following the theoretical analysis, we delve into a feasibility study. Here, we validate the theoretical predictions under controlled conditions to ensure the compatibility of our drug delivery system with your molecule. This step is crucial in identifying the unique opportunities and possible challenges that may arise. This phase involves:
    • Physicochemical characterization: Mean size, PDI and Zeta Potential
    • Association efficiency
    • Stability during storage (at 4ºC for up to 48 hours and 37ªC for up to 4 hours)
    • Colloidal stability in a specific biological fluid
  • Evaluation point: The final say rests with you. After the feasibility study, you have the choice to proceed further based on the results. Should the results be promising, we would then proceed to the subsequent stages of development. However, if the results do not meet your expectations, you are free to opt out. This process allows us to place your molecule at the center of our efforts, providing a structured,to explore the potential benefits of our advanced drug delivery system.
  • Full product development

Technical documents

A report summarizing the characterization of the propotypes will be provided.

1st production included (batch)

We will provide enough quantity of product for a pilot proof of concept study.

Option to a sublicence agreement

Our fresh IP allow us to offer a sublicence option for a specific indication.

High-quality products

Improved delivery systems for a wide range of therapeutic molecules